Non-dopaminergic drug treatment of Parkinson’s disease

By Müller T.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 557-572

Informa Healthcare

Access to resources Recommend Favorite

Existing dopaminergic therapies for Parkinson’s disease

By Dutta PhD Aloke K   Le MD   PhD Weidong  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1613-1625

Informa Healthcare

Access to resources Recommend Favorite

Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles

By Khasnavis Saurabh   Roy Avik   Ghosh Supurna   Watson Richard   Pahan Kalipada  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 218-232

Springer Publishing Company

Access to resources Recommend Favorite

Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 273-281

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 3: Drugs indirectly influencing the dopaminergic system (a review)

By Kadieva M.   Oganesyan É.   Mutsueva S.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 11, 2005-11 ,pp. : 565-573

Springer Publishing Company

Access to resources Recommend Favorite